Approval for the Implementation of Bioequivalence Testing.

UMKU Details

Parameter: All

Authority: Minister/Head of Agency

Requirements and Obligations:

  1. 1. Evidence of Payment of PNBP

    Duration: -

  2. 2. Compliance with the Standards and Requirements for the Approval of Bioequivalence Testing

    Duration: -

  3. 3. Compliance with the Standards and Requirements for the Approval of Clinical Trials

    Duration: -

  4. 4. Good Laboratory Practices (GLP) Standards

    Duration: -

Obligations:

  1. 1. Conduct Bioequivalence Testing in accordance with the approved protocol, Bioequivalence Testing Procedures, Good Clinical Practice (GCP) standards, and Good Laboratory Practices (GLP) during the conduct of bioequivalence testing.

    Duration: -

  2. 2. Report serious drug adverse effects.

    Duration: -

  3. 3. Report changes/amendments to bioequivalence testing documents.

    Duration: -

  4. 4. Report the completion of bioequivalence testing.

    Duration: -

  5. 5. Report the results of bioequivalence testing for drugs to be submitted for marketing authorization in Indonesia, submitted along with the drug registration documents.

    Duration: -

Sector: Drugs and Food.
Status: Available

Need advice on setting up a company in Indonesia?

KBLI.co.id is a subsidiary of Emerhub, the largest independet corporate advisory firm in Indonesia.

Schedule a free consultation
Share your plans for Indonesia with us, and our advisors will recommend the most appropriate type and classification of legal entity for your needs.
No commitment required
We recognize that you might be in the exploratory phase of deciding whether and how to expand into Indonesia. Allow us to simplify this process for you.
Always credible information
Due to frequent changes in regulations and government policies, there is a prevalence of misleading and outdated advice. As we handle company registrations daily, we are well-informed about the most current information.
Your planned activities in Indonesia